RESUMEN
Abstract Objective: To describe the dietary patterns and occurrence of metabolic disorders in children and adolescents with urolithiasis treatment at a referral hospital in southern Brazil in order to learn the features of urolithiasis in this population to better develop preventive actions. Methods: Descriptive study conducted between 2016 and 2017 in a tertiary care referral hospital. Fourty patients aged 2-19 years old with urolithiasis proven by imaging were included. Clinical and dietary data were obtained through interviews and medical records. For statistical analyses, the chi-squared test was performed. Results: 40 individuals were analyzed. Mean age at diagnosis was 7.2 ± 4 years. 25% were overweight or obese. 95% had metabolic disorders, hypocitraturia being the predominant type. Protein intake was adequate in all participants and carbohydrate intake, in 70% of them; 37.5% had lipid intake above recommended and 65% had low fiber intake. The mean daily sodium intake was 2.64 g (±1.74), with 55% of participants ingesting more than the recommended amount. A total of 52.5% had low potassium intake, with a mean of 4.79 g/day (±2.49). Calcium intake was adequate in 27.5%. No significant differences were identified in relation to mean daily consumption among participants with or without the various metabolic disorders. Conclusion: Pediatric urolithiasis is often accompanied by metabolic disorders; therefore, metabolic evaluation should be part of the diagnostic process and subsequent analysis of these patients' dietary patterns, helping to optimize treatment and prevent recurrences and complications.
Resumo Objetivo: Descrever o padrão alimentar e a ocorrência de distúrbios metabólicos em crianças e adolescentes portadoras de urolitíase acompanhadas em hospital de referências no sul do Brasil a fim de conhecer as particularidades da urolitíase nessa população para melhor desenvolver ações de prevenção. Métodos: Estudo observacional descritivo realizado entre 2016 e 2017 em centro de referência em atenção terciária. Foram selecionados 40 pacientes de dois a 19 anos com urolitíase comprovada por exame de imagem. Dados clínicos e alimentares foram obtidos através de prontuário e entrevista. Para análise estatística, utilizou-se o teste qui-quadrado. Resultados: Foram analisados 40 indivíduos, 55% masculinos. Idade média ao diagnóstico 7,2 ± 4 anos; 25% tinham sobrepeso ou obesidade; 95% tinham distúrbios metabólicos, predominou a hipocitratúria. O consumo proteico e de carboidratos foi adequado em 100% e 70% dos participantes, respectivamente, 37,5% apresentaram ingestão de lipídeos acima do recomendado e 65% apresentaram ingestão de fibras alimentares abaixo do recomendado. O consumo diário médio de sódio foi de 2,64 g (± 1,74), com 55% acima do recomendado; 52,5% apresentaram baixa ingestão de potássio com média de 4,79 g/dia (± 2,49). O consumo de cálcio foi adequado em 27,5%. Não foram identificadas diferenças significativas em relação ao consumo médio diário dos nutrientes entre os participantes com ou sem os diversos distúrbios metabólicos. Conclusões: A urolitíase pediátrica é frequentemente acompanhada de distúrbios metabólicos, o que confirma a necessidade de avaliação metabólica adequada ao diagnóstico e análise do padrão alimentar a fim de identificar erros alimentares, aprimorar o tratamento desses distúrbios e prevenir recorrências e complicações.
Asunto(s)
Humanos , Preescolar , Niño , Adolescente , Adulto Joven , Urolitiasis , Brasil , Dieta , Enfermedades Metabólicas , ObesidadRESUMEN
OBJECTIVE: To describe the dietary patterns and occurrence of metabolic disorders in children and adolescents with urolithiasis treatment at a referral hospital in southern Brazil in order to learn the features of urolithiasis in this population to better develop preventive actions. METHODS: Descriptive study conducted between 2016 and 2017 in a tertiary care referral hospital. Fourty patients aged 2-19 years old with urolithiasis proven by imaging were included. Clinical and dietary data were obtained through interviews and medical records. For statistical analyses, the chi-squared test was performed. RESULTS: 40 individuals were analyzed. Mean age at diagnosis was 7.2±4 years. 25% were overweight or obese. 95% had metabolic disorders, hypocitraturia being the predominant type. Protein intake was adequate in all participants and carbohydrate intake, in 70% of them; 37.5% had lipid intake above recommended and 65% had low fiber intake. The mean daily sodium intake was 2.64g (±1.74), with 55% of participants ingesting more than the recommended amount. A total of 52.5% had low potassium intake, with a mean of 4.79g/day (±2.49). Calcium intake was adequate in 27.5%. No significant differences were identified in relation to mean daily consumption among participants with or without the various metabolic disorders. CONCLUSION: Pediatric urolithiasis is often accompanied by metabolic disorders; therefore, metabolic evaluation should be part of the diagnostic process and subsequent analysis of these patients' dietary patterns, helping to optimize treatment and prevent recurrences and complications.
Asunto(s)
Urolitiasis , Adolescente , Brasil , Niño , Preescolar , Dieta , Humanos , Enfermedades Metabólicas , Obesidad , Adulto JovenRESUMEN
PURPOSE: Due to environmental and social changes (and possibly obesity) as new risk factors for stone formation in adults and changes in imaging techniques, we assessed whether etiologies of primary pediatric urolithiasis have changed, and if relationships exist between the condition and obesity or imaging technique. MATERIALS AND METHODS: All pediatric patients with documented primary urolithiasis who underwent serum and 24-hour urine analyses between 1999 and 2010 were evaluated. Age at diagnosis, gender, body mass index and imaging technique were recorded. RESULTS: Of the 222 patients (48% male) all had normal serum creatinine, electrolytes and minerals. Primary pediatric urolithiasis was diagnosed by ultrasound in 73% of cases and computerized tomography in 27%. Mean ± SD annual incidence of urolithiasis per 1,000 clinic visits increased from 2.4 ± 1.5 in the first half of the study period to 6.2 ± 2.1 in the second half (p <0.005). Mean ± SD age at diagnosis was 11.8 ± 3.8 years and body mass index was 21.7 ± 5.7 (rate of overweight 15%). A total of 140 patients had urine output less than 1.0 ml/kg per hour, with this being the only abnormality in 54. Hypercalciuria was observed in 46% of patients, hypocitraturia in 10% and high calcium-to-citrate ratio in 51%. Mild absorptive hyperoxaluria was noted in 3 patients and hyperuricosuria in 11, with all 14 exhibiting at least 1 additional abnormality. Cystinuria was present in 1 patient. No etiology was identified in 20 patients (9.0%). CONCLUSIONS: Oliguria and hypercalciuria continue to be the most common etiologies of pediatric primary urolithiasis, followed by hypocitraturia. The recent increase in stone incidence is unlikely due to increased use of computerized tomography. Incidence of obesity was not higher than in the general population. Hyperoxaluria and cystinuria are rare, and thus might not be indicated in the initial analysis.
Asunto(s)
Urolitiasis/diagnóstico , Urolitiasis/etiología , Adolescente , Niño , Preescolar , Femenino , Hospitales Pediátricos , Humanos , Lactante , Masculino , Obesidad/complicaciones , Estudios Retrospectivos , Factores de Tiempo , Urolitiasis/sangre , Urolitiasis/orinaRESUMEN
BACKGROUND: Recent studies suggest that cytokines modulate bone turnover. Idiopathic hypercalciuria (IH) seems to be associated with bone mineral loss. Therefore, the aim of this study was to assess cytokines involved in bone turnover in patients with IH. METHODS: Plasma and spot-urine levels of interleukin (IL)-1ß, IL-6, IL-8, tumor necrosis factor alpha (TNF-α), transforming growth factor ß1 (TGF-ß1), and monocyte chemoattractant protein (MCP-1) were measured in 70 children and adolescents with IH and in 37 healthy controls. Patients with IH were subdivided according to their calciuria at the time of sample collection: ≥4 mg/kg/day (persistent IH, n=27) and below 4 mg/kg/day (controlled IH, n=43). Cytokines were determined by enzyme-linked immunoassay. RESULTS: Plasma and urinary concentrations of IL-1ß, IL-6, IL-8, and TNF-α were undetectable in all groups. No differences were found between controlled and persistent hypercalciuria for plasma and urinary levels of MCP-1 and TGF-ß1. On the other hand, MCP-1 levels were significantly higher in both subgroups of IH in comparison to healthy controls. Furthermore, urinary MCP-1 levels of IH patients correlated positively with bone mineral content (p=0.013). CONCLUSION: Although cytokine measurements did not allow the differentiation between persistent and controlled IH, our findings suggest that MCP-1 might play a role in patients with IH.
Asunto(s)
Citocinas/sangre , Citocinas/orina , Hipercalciuria/inmunología , Absorciometría de Fotón , Adolescente , Factores de Edad , Biomarcadores/sangre , Biomarcadores/orina , Densidad Ósea , Remodelación Ósea , Brasil , Calcio/orina , Estudios de Casos y Controles , Quimiocina CCL2/sangre , Quimiocina CCL2/orina , Niño , Estudios Transversales , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Hipercalciuria/sangre , Hipercalciuria/diagnóstico por imagen , Hipercalciuria/orina , Interleucina-1beta/sangre , Interleucina-1beta/orina , Interleucina-6/sangre , Interleucina-6/orina , Interleucina-8/sangre , Interleucina-8/orina , Vértebras Lumbares/diagnóstico por imagen , Masculino , Factor de Crecimiento Transformador beta1/sangre , Factor de Crecimiento Transformador beta1/orina , Factor de Necrosis Tumoral alfa/sangre , Factor de Necrosis Tumoral alfa/orina , Adulto JovenRESUMEN
The pathogenesis of idiopathic nephrotic syndrome (INS) remains unknown. Several findings suggest a role for the immune system. This study aimed to evaluate immune mediators in INS by measuring plasma and urinary levels of transforming growth factor beta1 (TGF-beta1), monocyte chemoattractant protein-1 (MCP-1/CCL2), regulated on activation normal T-cell expressed and secreted (RANTES/CCL5) and IL-8 (IL-8/CXCL8) in pediatric patients with INS and in age-matched healthy controls. Patients were divided according to their response to corticosteroids: steroid-sensitive (SS, n = 8), or steroid-resistant (SR, n = 24). Immune mediators were also compared in regard with disease activity (relapse and remission). Immune mediators were measured by ELISA. Plasma TGF-beta1 levels in SR patients were approximately 2.8-fold higher than control values (p < 0.05). Urinary IL-8/CXCL8 was 2.9-fold higher in INS patients in relapse (proteinuria >100 mg/m2/24 h) when compared with patients in remission (p < 0.05), and levels had a positive correlation with individual proteinuria values (p < 0.05). Urinary IL-8/CXCL8 was significantly higher in relapsed SR than in SS patients in remission. No changes in MCP-1/CCL2 and RANTES/CCL5 levels were detected. Our findings suggest that IL-8/CXCL8 and TGF-beta1 are involved in the pathogenesis of INS: IL-8/CXCL8 associated with local changes in glomerular permeability and TGF-beta1 could be related to worse response to corticosteroids.
Asunto(s)
Factores Inmunológicos , Interleucina-8/inmunología , Síndrome Nefrótico , Proteinuria/inmunología , Adolescente , Quimiocina CCL2/sangre , Quimiocina CCL2/orina , Quimiocina CCL5/sangre , Quimiocina CCL5/orina , Niño , Femenino , Humanos , Factores Inmunológicos/sangre , Factores Inmunológicos/inmunología , Factores Inmunológicos/orina , Interleucina-8/sangre , Interleucina-8/orina , Masculino , Síndrome Nefrótico/metabolismo , Síndrome Nefrótico/fisiopatología , Proteinuria/sangre , Proteinuria/orina , Factor de Crecimiento Transformador beta1/sangre , Factor de Crecimiento Transformador beta1/orinaRESUMEN
Objetivo: analisar a história clínica e evolução de crianças e adolescentes com HI, ressaltando peculiariades próprias destes pacientes. Métodos: 471 pacientes de HI têm sido acompanhados em regime ambulatorial, sendo submetidos ao protocolo: Rx de abdome, ultrassonografia de rins e vias urinárias; ionograma, gasometria e bioquímica de sangue; urina de 24 horas para dosagem de cálcio e outros eletrólitos e creatinina; urinálise, urocultura e microscopia de contraste de fase; urina de segunda micção matinal em jejum para dosagem de cálcio e creatinina. Resultados: 56 por cento masculinos e 44 por cento femininos; 56 brancos, 37 por cento não-brancos e 7 por cento sem relato de cor da pele. Ao diagnóstico 6 por cento eram lactentes, 15 por cento pré-escolares, 55 por cento escolares e 24 por cento adolescentes, 47 por cento tinha hematúria associada à dor abdominal, 31 por cento hematúria isolada, 14 por cento dor abdominal isolada, 8 por cento tinham infecção urinária, enurese noturna, dor suprapúbica ou uretral ou a síndrome miccional com frequência/urgência e incontinência urinária. A associação de hipercalciúria com litíase do trato urinário foi positiva em 56 por cento dos pacientes. Em 18,5 por cento houve associação com hiperuricosúria e em 8,5 por cento com hipocitratúria. 33 por cento dos pacientes tiveram má evolução com recorrência de nefrolitíase, persistência de hematúria e dor abdominal. Conclusões: a HI deve ser diagnosticada e tratada criteriosamente com o objetivo de reduzir suas consequências como hematúria, dor abdominal, formação de cálculos urinários e as possíveis alterações ósseas. Sinais e sintomas como urgência e incontinência urinárias, dor suprapúbica e enurese noturna podem ter como causa a hiperexcreção renal de cálcio